South Florida has a rich history of medical device innovation, and we are pleased to be able to continue in that tradition.” “We also announced that the FDA has approved our IDE application allowing ...
InspireMD, Inc. (NSPR) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.20. This compares to loss of $0.15 per share a year ago. These figures are ...
San Diego, United States - 08, 2024 In a high-stakes operation over the Veteran's Day weekend, the U.S. Air Force's 129th ...
The Lupus Foundation of America (LFA) is proud to honor two exceptional lupus researchers at the 2024 Evelyn V. Hess ...
Inpatient care, refers to the provision of medical treatment for patients who have been admitted ... to the National Stock ...
The Horizon Inspire System. [Image courtesy of Magstim] Magstim announced today that the FDA cleared its next-generation ...